ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Free Cash Flow
ESSA Pharma Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Free Cash Flow
$-21.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Free Cash Flow
$-122.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Free Cash Flow
$-85.7m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Free Cash Flow
$-34.2m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-22%
|
|
Sunshine Biopharma Inc
OTC:SBFM
|
Free Cash Flow
$-9.6m
|
CAGR 3-Years
-144%
|
CAGR 5-Years
-78%
|
CAGR 10-Years
-33%
|
See Also
What is ESSA Pharma Inc's Free Cash Flow?
Free Cash Flow
-21.6m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Free Cash Flow amounts to -21.6m USD.
What is ESSA Pharma Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-16%
Over the last year, the Free Cash Flow growth was 23%. The average annual Free Cash Flow growth rates for ESSA Pharma Inc have been -7% over the past three years , -16% over the past five years .